CVS Health initiates FY24 guidance of at least $8.50 adj EPS, raises dividend 10%

CVS HEALTH Corp

Introduces CVS CostVantage and CVS Caremark TrueCost for transparent pharmacy reimbursement, launch in 2025.
Launches CVS Healthspire brand for Health Services segment including Caremark, Oak Street, Signify, MinuteClinic.
Reiterates FY23 guidance; initiates FY24 projections: revenue >=$366B, adj EPS >=$8.50.
Board approves quarterly dividend increase to $0.665/share (+10%), payable Feb 1, 2024.
Aetna achieves 87% of Medicare Advantage members in 4-star+ plans for 2025, up from 21%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.